Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.

about

Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.

P2860

Q47728264-4DAAEFF1-1AC4-4FD3-BBC3-6B189822110F

P2860

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.

Item

http://www.wikidata.org/entity/Q36853674

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Outcomes of neoadjuvant chemor ...... ced rectal carcinoma patients.

@en

type

Item

label

Outcomes of neoadjuvant chemor ...... ced rectal carcinoma patients.

@en

prefLabel

Outcomes of neoadjuvant chemor ...... ced rectal carcinoma patients.

@en

P1476

Outcomes of neoadjuvant chemor ...... ced rectal carcinoma patients.

@en

P2093

Katsuji Tokuhara

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Yoshioka

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Nakatani

http://www.w3.org/2001/XMLSchema#string

Masanori Kon

http://www.w3.org/2001/XMLSchema#string

Yosuke Ueyama

http://www.w3.org/2001/XMLSchema#string

P2860

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Locally advanced rectal cancer: the importance of a multidisciplinary approach.

Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.

Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer

High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.

P2888

s12957-016-0898-1

P304

136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-016-0898-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046187618

http://www.w3.org/2001/XMLSchema#string

P698

27129578

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4851776

http://www.w3.org/2001/XMLSchema#string

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.

about

P2860

P2860

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932